Atlas Genetics Ltd of the UK has appointed Jeffrey Luber as its chief executive, succeeding the founding CEO John Clarkson, who has become executive chairman. Mr Luber will direct the commercialisation of the company’s diagnostic products. He joins from the US screening company Good Start Genetics Inc. He was also CEO of Exact Sciences Corp where he executed a strategic transaction with Genzyme Corp.
Atlas Genetics announced the appointment on 3 October 2017.
Copyright 2017 Evernow Publishing Ltd